| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192117 | Annals of Allergy, Asthma & Immunology | 2011 | 10 Pages |
Abstract
Improvement in clinically relevant control end points occurred in both BUD/FM and BUD groups; both treatments were well tolerated in this Hispanic asthma population but were not significantly differentiated.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
James MD, Lyndon E. MD, Tom MS, Christopher D. MD, PhD,